Pharmos Ltd.
Loteprednol etabonate - tobramcyin: A Novel Steriod/Antibiotic — Israeli partner. US partner: Bausch & Lomb (blp) Inc. (TAMPA (Florida)). Sector: Life Sciences, Medical Devices. The joint development of ‘loteprednol etabonate’ (LE) by Pharmos and Bausch & Lomb, funded by the BIRD Foundation, resulted in the fundamental formulation for the development of Lotemax, the No. 1 dispensed ophthalmic steroid brand in America, and Alrex, the treatment of choice among many eye-care professionals in the United States for severe seasonal allergic conjunctivitis.